Last C$0.06 CAD
Change Today 0.00 / 0.00%
Volume 30.0K
MIR On Other Exchanges
Symbol
Exchange
Venture
OTC US
Frankfurt
As of 9:30 AM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

medmira inc (MIR) Snapshot

Open
C$0.06
Previous Close
C$0.06
Day High
C$0.06
Day Low
C$0.06
52 Week High
01/29/14 - C$0.14
52 Week Low
12/16/14 - C$0.05
Market Cap
29.5M
Average Volume 10 Days
162.9K
EPS TTM
C$-0.0070
Shares Outstanding
536.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDMIRA INC (MIR)

Related News

No related news articles were found.

medmira inc (MIR) Related Businessweek News

No Related Businessweek News Found

medmira inc (MIR) Details

MedMira Inc., a biotechnology company, engages in the research, development, manufacture, and sale of rapid diagnostics and technology platforms. Its research is focused on specific areas of the diagnostics market, including rapid, point-of-care, and in vitro sectors. Its products include Reveal HIV, which detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal HP/Rapid H. Pylori antibody tests that detect helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection; Reveal TP, a rapid syphilis antibody test, which detects treponema pallidum (TP) antibodies; Multiplo, a line of multiplex tests that combines testing solutions for HIV-1/2, Hepatitis B and C, and Syphilis in whole blood, serum, or plasma; and Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics. MedMira Inc. sells its rapid tests under the Reveal, Multiplo, and Miriad brands through a network of medical distributors and strategic business development partners with customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care facilities, governments, and public health agencies. The company sells and distributes its products in North America, Latin America and the Caribbean, Europe, the Asia Pacific, and the Middle East. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of Onsite Lab Holding AG.

Founded in 1993

medmira inc (MIR) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: C$188.0K
Chief Financial Officer
Total Annual Compensation: C$7.6K
Compensation as of Fiscal Year 2014.

medmira inc (MIR) Key Developments

MedMira Inc. Reports Revenue Results for the First Quarter Ended October 31, 2014

MedMira Inc. reported revenue results for the first quarter ended October 31, 2014. For the quarter, the company recorded revenue in the quarter totaling $521,178, which included product sales, related royalties, and service sales, as compared to $472,846 for the same period last year.

MedMira Inc. Reports Financial Results for the First Quarter Ended October 31, 2014

MedMira Inc. reported financial results for the first quarter ended October 31, 2014. The company recorded revenue in the quarter totaling $521,178, which included product sales, related royalties, and service sales, as compared to $472,846 for the same period last year. The company's revenue from product sales and related royalties in the quarter was $232,372 as compared to $174,720 for the same period last year. This increase in product revenue by 33% was due to greater demand in the USA, Latin American and Indian market. Gross profit on product sales for the quarter was $109,278 (47%) compared to $93,731 (54%) in the same period in 2014. The company's revenue from service sales for the quarter was $288,806 as compared to $298,126 for the same period last year. Gross profit on service revenue was $84,572 (29%) compared to $46,701 (16%) in the same period in 2014.

MedMira Inc. Announces Sales Results for the Fourth Quarter and Year Ended July 31, 2014

MedMira Inc. announced sales results for the fourth quarter and year ended July 31, 2014. For the quarter, the company reported total revenue of $897,980 compared to $596,115 for the same period in 2013. For the year, the company reported revenue of $2,528,179, which included product sales, related royalties, and service sales, as compared to $2,001,464 for the same period last year, which included product sales, service revenues and related royalties, an increase of $526,715. Company's revenue from product sales and related royalties in the year ended July 31, 2014 was $854,468 as compared to $864,798 for the same period last year. This decrease in product revenue by 1.2% was due to delays in tenders in China which were awarded subsequent to the year end. Gross profit on product sales was $418,062 compared to $429,389 in the same period in 2013. The company's revenue from service sales for the year ended July 31, 2014 was $1,673,711 as compared to $1,136,666 for the same period last year. Gross profit on service revenue was $356,733 compared to $201,386 in the same period in 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MIR:CN C$0.06 CAD 0.00

MIR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MIR.
View Industry Companies
 

Industry Analysis

MIR

Industry Average

Valuation MIR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.5x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDMIRA INC, please visit www.medmira.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.